RNA – JoelGalvan

Business

Expands Genetic Hearing Loss Pipeline with $1.3B RNA Therapy Partnership

2 min read

Posted on May 19, 2025

by Joelgalvan

On May 16, Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural…